We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $911M
1-Year Est. Return 51.11%
This Fund
S&P 500
This Quarter Est. Return
+3.42%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$2.07B
AUM Growth
-$113M
Cap. Flow
-$164M
Cap. Flow %
-7.94%
Top 10 Hldgs %
31.22%
Holding
172
New
56
Increased
31
Reduced
28
Closed
49

Top Buys

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$62.2M
2
NTRS icon
Northern Trust
NTRS
+$29.5M
3
TSN icon
Tyson Foods
TSN
+$28.2M
4
LNC icon
Lincoln National
LNC
+$26.6M
5
META icon
Meta Platforms (Facebook)
META
+$25.4M

Top Sells

Rank Stock Value
1
NWL icon
Newell Brands
NWL
+$69.9M
2
AMZN icon
Amazon
AMZN
+$56.7M
3
CDK
CDK Global, Inc.
CDK
+$41.4M
4
HLF icon
Herbalife
HLF
+$39.5M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$38.2M

Sector Composition

Rank Sector Weight
1 Healthcare 14.31%
2 Consumer Discretionary 9.33%
3 Consumer Staples 7.58%
4 Energy 7.07%
5 Industrials 7.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCTL
101
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$2.51M 0.12%
346,845
+218,620
+170% +$1.5M
AGN.PRA
102
DELISTED
Allergan plc
AGN.PRA
$2.29M 0.11%
+3,000
New +$2.27M
ADM icon
103
Archer Daniels Midland
ADM
$37.6B
$2.28M 0.11%
+50,000
New +$2.21M
CLCD
104
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
$2.2M 0.11%
60,461
-94,502
-61% -$3.34M
PTCT icon
105
CALL
PTC Therapeutics
PTCT
$5.68B
$2.18M 0.11%
+200,000
New +$2.1M
SHPG
106
DELISTED
Shire pic
SHPG
$2.03M 0.1%
+11,900
New +$2.11M
CBAY
107
DELISTED
Cymabay Therapeutics
CBAY
$1.63M 0.08%
941,348
-17,474
-2% -$30.8K
ARCT icon
108
Arcturus Therapeutics
ARCT
$171M
$1.36M 0.07%
92,857
+36,171
+64% +$541K
KR icon
109
Kroger
KR
$35.7B
$1.21M 0.06%
35,000
-64,200
-65% -$2.09M
ALPN
110
DELISTED
Alpine Immune Sciences Inc
ALPN
$1.17M 0.06%
129,978
-5,447
-4% -$109K
ARIA
111
PUT
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$995K 0.05%
80,000
-20,000
-20% -$241K
JAGX icon
112
Jaguar Health
JAGX
$4.91M
– –
0
– –
CPRX
113
DELISTED
Catalyst Pharmaceutical
CPRX
$794K 0.04%
+756,311
New +$864K
MDLZ icon
114
Mondelez International
MDLZ
$78.8B
$663K 0.03%
+14,951
New +$644K
TNXP icon
115
Tonix Pharmaceuticals
TNXP
$170M
– –
0
– –
KDMN
116
DELISTED
Kadmon Holdings, Inc.
KDMN
$287K 0.01%
54,333
– –
DVAX
117
CALL
DELISTED
Dynavax Technologies
DVAX
$257K 0.01%
65,100
-1,140,200
-95% -$8.35M
ISEE
118
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$97K ﹤0.01%
20,000
-13,100
-40% -$389K
ASRT
119
PUT
DELISTED
Assertio
ASRT
– –
-1,667
Closed -$2.5M
BHC icon
120
CALL
Bausch Health
BHC
$2.62B
– –
-300,700
Closed -$7.38M
BXMT icon
121
Blackstone Mortgage Trust
BXMT
$2.46B
– –
-324,000
Closed -$9.54M
C icon
122
CALL
Citigroup
C
$224B
– –
-501,100
Closed -$23.7M
C icon
123
Citigroup
C
$224B
– –
-694,733
Closed -$37.5M
CB icon
124
Chubb
CB
$134B
– –
-193,705
Closed -$24.3M
CCEP icon
125
Coca-Cola Europacific Partners
CCEP
$47.8B
– –
-178,808
Closed -$7.13M
3 4
5
6 7

Similar funds

GC
Greenvale Capital London, United Kingdom $912M AUM 34.2% 1-Year Est. Return
ICP
Ironvine Capital Partners Omaha, Nebraska $910M AUM 10.64% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return
SAA
Southeast Asset Advisors Thomasville, Georgia $913M AUM 25.32% 1-Year Est. Return
GIG
Goodnow Investment Group Darien, Connecticut $913M AUM 11.84% 1-Year Est. Return
SI
Symmetry Investments St Helier, Jersey $913M AUM 30.59% 1-Year Est. Return
PAMI
Perseverance Asset Management International George Town, Cayman Islands $909M AUM 17.42% 1-Year Est. Return
BDP
Brehaut David Pascal $908M AUM

Kingdon Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Kingdon Capital Management held 172 positions worth $2.07B, down 5.2% from $2.18B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Kingdon Capital Management withdrew a net $164M in Q4 2016, closing 49 positions and reducing 28 holdings. Its most notable exit was CDK Global, Inc., an estimated $41.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

Against the trend, Kingdon Capital Management opened a new position in Union Pacific worth $65.6M.

  • Kingdon Capital Management's largest Q4 2016 buy was Union Pacific: 632,510 shares worth $65.6M.
  • Kingdon Capital Management added most to Tyson Foods in Q4 2016, an estimated $28.2M increase.
  • Kingdon Capital Management's biggest Q4 2016 reduction was Newell Brands, cutting an estimated $69.9M.
  • Kingdon Capital Management fully exited CDK Global, Inc. in Q4 2016, selling an estimated $41.4M.
  • Kingdon Capital Management's ten largest holdings make up 31% of its $2.07B portfolio in Q4 2016.
  • Kingdon Capital Management opened 56 new positions and closed 49 in Q4 2016.
  • Kingdon Capital Management's portfolio value fell 5.2% quarter-over-quarter to $2.07B.

Based on Kingdon Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.